Exploring GLP-1 Receptor Agonists for Neurodegeneration - Part 2

episode

Neurology Minute not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Reacting to Islamic Apologists | GodLogic | Last Call Ep. 33 34 min · 24 Sep 2026 · Pints With Aquinas

Bond bombshell 22 min · 24 Sep 2026 · Unhedged

Do you have the correct time? 29 min · 24 Sep 2026 · BBC Inside Science

The High Schools Going All-In on AI 20 min · 24 Sep 2026 · The Journal.

Rosa Parks and the Montgomery Bus Boycott: Fighting to End Segregation 3h 6m · 24 Sep 2026 · Sleepy History

TNB Tech Minute: OpenAI Agents Attempt to Hack University and Government Websites 3 min · 24 Sep 2026 · WSJ Tech News Briefing

Report any issue

Source

Recorded28 Feb 2025

Publisherneurologyminute.libsyn.com ↗

Handlerec:10217505

Show notes

In part two of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss the preclinical data and epidemiological data that led us to the phase three study on exenatide. Show reference: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00161-8/abstract

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in